Jason Aryeh, Director at LIGAND PHARMACEUTICALS INC (LGND), bought 4,004 shares at $93.00 ($397K) on 2019-07-31, disclosed to the SEC on 2019-07-31.
Open-market purchase of $397k LGND by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.01 | 250 | $27K | 6.7% |
| 2 | $100.22 | 3,000 | $301K | 75.7% |
| 3 | $93.00 | 754 | $70K | 17.7% |
| Total | $99.22 avg | 4,004 | $397K | 100% |
| Filing → |
| OBIO | BUY | 2026-05-19 | $35K | — | Filing → |
| LGND | SELL | 2025-09-24 | $3.4M | — | Filing → |
| OBIO | BUY | 2025-09-19 | $2K | — | Filing → |